POSC248 Real-World Patient Characteristics and Treatment Patterns in Non-Small Cell Lung Cancer (NSCLC) Patients with KRAS P.G12C Mutant Tumors in Italy

U Malapelle,M Giannopoulou,A Moscetti,V Laino,F Passiglia

doi:10.1016/j.jval.2021.11.815

POSC248 Real-World Patient Characteristics and Treatment Patterns in Non-Small Cell Lung Cancer (NSCLC) Patients with KRAS P.G12C Mutant Tumors in Italy

U Malapelle, M Giannopoulou + Show 3 more

Open Access

https://doi.org/10.1016/j.jval.2021.11.815

Copy DOI

Journal: Value in Health	Publication Date: Jan 1, 2022
License type: publisher-specific-oa

Affiliation: University of Naples Federico II, Amgen (Switzerland), Biogen (Italy), Ospedale San Luigi Gonzaga

#Mutant Non-Small Cell Lung Cancer #Non-Small Cell Lung Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Inhibition of KRAS, and particularly mutant KRAS p.G12C, has been the focus of extensive research in NSCLC but information on how these patients are managed in the real-world setting in Italy is limited. This study aimed to describe the clinical characteristics and treatment patterns in patients with locally advanced and unresectable or metastatic KRAS p.G12C mutant NSCLC in Italy.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Value in Health

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.